Keyphrases
Monotherapy
100%
Rodents
100%
Metformin
100%
Myocardial Substrate Metabolism
100%
Rosiglitazone
100%
Metabotype
100%
Differential Effectiveness
100%
Glucose Utilization
50%
Cardiac Function
33%
Type 2 Diabetes Mellitus (T2DM)
16%
Fractional Shortening
16%
Cardiovascular Disease
16%
Small Animal Positron Emission Tomography
16%
Decreased Expression
16%
Glucose Transporter 4 (GLUT4)
16%
Echocardiography
16%
Leading Causes of Death
16%
Glucose Uptake
16%
Fatty Acid Oxidation
16%
Diabetic Patients
16%
Expression Analysis
16%
Euthanized
16%
GLUT Transporters
16%
Diabetic Heart
16%
ZDF Rats
16%
Esterification
16%
Circ
16%
Fatty Acid Transport
16%
Medicine and Dentistry
Monotherapy
100%
Rosiglitazone
100%
Metformin Plus Rosiglitazone
100%
Glucose Utilization
75%
Glycon
50%
Heart Function
50%
Diabetes Mellitus
50%
Positron Emission Tomography
25%
Maturity Onset Diabetes of the Young
25%
Cardiovascular Disease
25%
Echocardiography
25%
Glucose Uptake
25%
Glucose Transporter
25%
Fatty Acid Oxidation
25%
Fatty Acid Transport
25%
Expression Analysis
25%
Glucose Transporter 4
25%
Pharmacology, Toxicology and Pharmaceutical Science
Monotherapy
100%
Rosiglitazone
100%
Metformin Plus Rosiglitazone
100%
Diabetes Mellitus
50%
Metformin
50%
Fatty Acid
25%
Glucose Transporter 4
25%
Glucose Transporter
25%
Zucker Diabetic Fatty Rat
25%
Non Insulin Dependent Diabetes Mellitus
25%
Cardiovascular Disease
25%